Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04985331 · ClinicalTrials.gov registry record · NA
Digital Therapeutic vs Psychoeducation for Management of Mild to Moderate Depression in Adolescents
A NA study of Depression, Teen, sponsored by Woebot Health.
- Completed
- Registry status
- NA
- Development phase
- 246
- Enrollment target
- 1
- Study location
NCT04985331: Completed NA study of Depression, Teen, sponsored by Woebot Health.
NCT04985331 is a NA study of Depression, Teen that has completed, run by Woebot Health. The registered enrollment target is 246 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04985331, a NA study of Depression, Teen, has completed, sponsored by Woebot Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 246 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the present randomized controlled study is to investigate if there is a difference in depression symptoms at 4-weeks among adolescents ages 16-17 years assigned to W-GenZD, a digital therapeutic, as compared to a psychoeducational control group.
Primary Outcome
Measure of depression severity. Total score between 0-27, where higher scores indicate greater levels of depression.
Conditions Studied
Interventions
- DEVICE W-GenZD
Study Locations (1)
California
- Woebot Health - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 246 participants |
| Start Date | 2021-08-02 |
| Est. Completion | 2022-01-04 |
| Phase | NA |
What the finished NCT04985331 record still lists
NCT04985331 is an interventional study that assigns participants to a tested intervention. The registered 246 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Depression, Teen appearing as the primary indexed condition, and to 1 intervention - of which W-GenZD is the first listed.
NCT04985331 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04985331 about?
NCT04985331 is a clinical study titled "Digital Therapeutic vs Psychoeducation for Management of Mild to Moderate Depression in Adolescents". The purpose of the present randomized controlled study is to investigate if there is a difference in depression symptoms at 4-weeks among adolescents ages 16-17 years assigned to W-GenZD, a digital therapeutic, as compared to a psychoeducational control group.
What is the current status of trial NCT04985331?
This trial is currently completed. It is a NA study. The enrollment target is 246 participants. The study started on 2021-08-02. Estimated completion is 2022-01-04.
What conditions does trial NCT04985331 study?
This clinical trial studies the following conditions: Depression, Teen.
What interventions are being tested in trial NCT04985331?
The interventions under investigation include: W-GenZD (DEVICE).
Who is sponsoring clinical trial NCT04985331?
This trial is sponsored by Woebot Health, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04985331 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression, Teen
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04985331's enrollment target sits among peer trials
246 436th of 2000 higher than 1,565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04973605 · 246 participants · Phase 1
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
- NCT06395168 · 246 participants · NA
Mayo Clinic Health System Northwest Wisconsin Integrated Maternal Postpartum Appointment Combination
- NCT07048769 · 246 participants · Phase 4
Paracervical Block for Pain Reduction in Saline Infusion Sonograms
- NCT07176650 · 246 participants · Phase 1
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI